Peptides Identified Through Phage Display for Prostate Cancer Imaging and TherapyWei Wang1, Moze Tong1, Yanbin Zhang1 and Yongping Chen 1,2 *
- *Corresponding Author:
- Yongping Chen
W ashington Biotechnology Inc
6200 Seaforth Street, Baltimore
Maryland 21224, USA
Tel: +1 410-633-9210
E-mail: yongpingc[email protected]
Received date: October 26, 2015; Accepted date: October 27, 2015; Published date: November 02, 2015
Citation: Wang W, Tong M, Zhang Y, Chen YP (2015) Peptides Identified Through Phage Display for Prostate Cancer Imaging and Therapy. J Pharmacogenomics Pharmacoproteomics 6:e150. doi: 10.4172/2153-0645.1000e150
Copyright: © 2015 Wang W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Prostate cancer is the second highest cause of cancer death among the world. It is important to identify the target molecules for prostate cancer early detection and targeted therapy. In this mini review, we discuss some of peptides identified through phage display for molecular imaging and targeted therapy of prostate cancer.